Excitotoxicity mediated by non-NMDA receptors causes distal axonopathy in long-term cultured spinal motor neurons

European Journal of Neuroscience

Volumn 26, Issue 8, 2007, Pages 2151-2159

  King, A E ^a   Dickson, T C ^a   Blizzard, C A ^a   Foster, S S ^a   Chung, R S ^a   West, A K ^a   Chuah, M I ^a   Vickers, J C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

ALS; Kainic acid; MND; Neurofilament; Spheroid

Indexed keywords

CYTOSKELETON PROTEIN; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROFILAMENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DISRUPTION; CELL MATURATION; CONTROLLED STUDY; EXCITOTOXICITY; IN VITRO STUDY; NERVE CELL CULTURE; NERVE FIBER DEGENERATION; NEUROFILAMENT; NEUROPATHY; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SPINAL CORD MOTONEURON; SPINAL CORD NERVE CELL;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; AXONS; CELLS, CULTURED; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EMBRYO, MAMMALIAN; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; KAINIC ACID; MICROTUBULE-ASSOCIATED PROTEINS; MOTOR NEURONS; N-METHYLASPARTATE; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; RATS; RECEPTORS, GLUTAMATE; SPINAL CORD; TIME FACTORS;

EID: 35448976852     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05845.x     Document Type: Article

References (51)

1. Ackerley, S., Grierson, A.J., Brownlees, J., Thornhill, P., Anderton, B.H., Leigh, P.N., Shaw, C.E. Miller, C.C. (2000) Glutamate slows axonal transport of neurofilaments in transfected neurons. J. Cell Biol., 150, 165 176.
2. Bar, P.R. (2000) Motor neuron disease in vitro: the use of cultured motor neurons to study amyotrophic lateral sclerosis. Eur. J. Pharmacol., 405, 285 295.
3. Bar-Peled, O., O'Brien, R.J., Morrison, J.H. Rothstein, J.D. (1999) Cultured motor neurons possess calcium-permeable AMPA/kainate receptors. Neuroreport, 10, 855 859.
4. Bruijn, L.I., Miller, T.M. Cleveland, D.W. (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci., 27, 723 749.
5. Carriedo, S.G., Yin, H.Z. Weiss, J.H. (1996) Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci., 16, 4069 4079.
6. Ching, G.Y., Chien, C.L., Flores, R. Liem, R.K. (1999) Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice. J. Neurosci., 19, 2974 2986.
7. Chung, R.S., Adlard, P.A., Dittmann, J., Vickers, J.C., Chuah, M.I. West, A.K. (2004) Neuron-glia communication: metallothionein expression is specifically up-regulated by astrocytes in response to neuronal injury. J. Neurochem., 88, 454 461.
8. Chung, R.S., McCormack, G.H., King, A.E., West, A.K. Vickers, J.C. (2005) Glutamate induces rapid loss of axonal neurofilament proteins from cortical neurons in vitro. Exp. Neurol., 193, 481 488.
9. Cifuentes-Diaz, C., Nicole, S., Velasco, M.E., Borra-Cebrian, C., Panozzo, C., Frugier, T., Millet, G., Roblot, N., Joshi, V. Melki, J. (2002) Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum. Mol. Genet., 11, 1439 1447.
10. Delisle, M.B. Carpenter, S. (1984) Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J. Neurol. Sci., 63, 241 250.
11. Dickson, T.C., Chuckowree, J.A., Chuah, M.I., West, A.K. Vickers, J.C. (2005) alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury. Neurobiol. Dis., 18, 286 295.
12. Fischer, L.R., Culver, D.G., Tennant, P., Davis, A.A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M.A. Glass, J.D. (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol., 185, 232 240.
13. Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W. Caroni, P. (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci., 20, 2534 2542.
14. Goldstein, M.E., Sternberger, N.H. Sternberger, L.A. (1987) Phosphorylation protects neurofilaments against proteolysis. J. Neuroimmunol., 14, 149 160.
15. Goodall, E.F. Morrison, K.E. (2006) Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev. Mol. Med., 8, 1 22.
16. Gotow, T. (2000) Neurofilaments in health and disease. Med. Electron Microsc., 33, 173 199.
17. Gould, T.W., Buss, R.R., Vinsant, S., Prevette, D., Sun, W., Knudson, C.M., Milligan, C.E. Oppenheim, R.W. (2006) Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci., 26, 8774 8786.
18. Hasbani, M.J., Hyrc, K.L., Faddis, B.T., Romano, C. Goldberg, M.P. (1998) Distinct roles for sodium, chloride, and calcium in excitotoxic dendritic injury and recovery. Exp. Neurol., 154, 241 258.
19. Heath, P.R. Shaw, P.J. (2002) Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve, 26, 438 458.
20. Hirano, A. (1991) Cytopathology of amyotrophic lateral sclerosis. Adv. Neurol., 56, 91 101.
21. Ikonomidou, C., Qin Qin, Y., Labruyere, J. Olney, J.W. (1996) Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol., 55, 211 224.
22. Katsuno, M., Adachi, H., Minamiyama, M., Waza, M., Tokui, K., Banno, H., Suzuki, K., Onoda, Y., Tanaka, F., Doyu, M. Sobue, G. (2006) Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. J. Neurosci., 26, 12106 12117.
23. Kiernan, M.C. (2005) Riluzole: a glimmer of hope in the treatment of motor neurone disease. Early experience confirms that riluzole improves survival and is well tolerated. Med. J. Aust., 182, 319 320.
24. King, A.E., Chung, R.S., Vickers, J.C. Dickson, T.C. (2006) Localization of glutamate receptors in developing cortical neurons in culture and relationship to susceptibility to excitotoxicity. J. Comp. Neurol., 498, 277 294.
25. LaMonte, B.H., Wallace, K.E., Holloway, B.A., Shelly, S.S., Ascano, J., Tokito, M., Van Winkle, T., Howland, D.S. Holzbaur, E.L. (2002) Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron, 34, 715 727.
26. Liu, Q., Xie, F., Siedlak, S.L., Nunomura, A., Honda, K., Moreira, P.I., Zhua, X., Smith, M.A. Perry, G. (2004) Neurofilament proteins in neurodegenerative diseases. Cell. Mol. Life Sci., 61, 3057 3075.
27. Miller, C.C., Ackerley, S., Brownlees, J., Grierson, A.J., Jacobsen, N.J. Thornhill, P. (2002) Axonal transport of neurofilaments in normal and disease states. Cell. Mol. Life Sci., 59, 323 330.
28. Nihei, K., McKee, A.C. Kowall, N.W. (1993) Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol. (Berl.), 86, 55 64.
29. Pasinelli, P. Brown, R.H. (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci., 7, 710 723.
30. Rothstein, J.D., Jin, L., Dykes-Hoberg, M. Kuncl, R.W. (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl Acad. Sci. USA, 90, 6591 6595.
31. Rothstein, J.D. (1996) Excitotoxicity hypothesis. Neurology, 47, S19 S25 Discussion S26.
32. Sasaki, S. Maruyama, S. (1994) Synapse loss in anterior horn neurons in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.), 88, 222 227.
33. Sasaki, S. Iwata, M. (1996) Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology, 47, 535 540.
34. Sasaki, S., Warita, H., Abe, K. Iwata, M. (2005) Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. (Berl.), 110, 48 56.
35. Sternberger, L.A. Sternberger, N.H. (1983) Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl Acad. Sci. USA, 80, 6126 6130.
36. Sun, H., Kawahara, Y., Ito, K., Kanazawa, I. Kwak, S. (2006) Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS. J. Neurochem., 98, 782 791.
37. Tekkok, S.B., Faddis, B.T. Goldberg, M.P. (2005) AMPA/kainate receptors mediate axonal morphological disruption in hypoxic white matter. Neurosci. Lett., 382, 275 279.
38. Terro, F., Lesort, M., Dussartre, C., Barthe, D. Hugon, J. (1996) Phosphorylated neurofilament expression and resistance to kainate toxicity. Brain Res. Bull., 41, 231 235.
39. Troy, C.M., Muma, N.A., Greene, L.A., Price, D.L. Shelanski, M.L. (1990) Regulation of peripherin and neurofilament expression in regenerating rat motor neurons. Brain Res., 529, 232 238.
40. Tsang, Y.M., Chiong, F., Kuznetsov, D., Kasarskis, E. Geula, C. (2000) Motor neurons are rich in non-phosphorylated neurofilaments: cross-species comparison and alterations in ALS. Brain Res., 861, 45 58.
41. Van Damme, P., Van Den Bosch, L., Van Houtte, E., Callewaert, G. Robberecht, W. (2002) GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. J. Neurophysiol., 88, 1279 1287.
42. Vandenberghe, W., Van Den Bosch, L. Robberecht, W. (1998) Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system. Brain Res., 807, 1 10.
43. Vartiainen, N., Tikka, T., Keinanen, R., Chan, P.H. Koistinaho, J. (1999) Glutamatergic receptors regulate expression, phosphorylation and accumulation of neurofilaments in spinal cord neurons. Neuroscience, 93, 1123 1133.
44. Vickers, J.C., Huntley, G.W., Edwards, A.M., Moran, T., Rogers, S.W., Heinemann, S.F. Morrison, J.H. (1993) Quantitative localization of AMPA/kainate and kainate glutamate receptor subunit immunoreactivity in neurochemically identified subpopulations of neurons in the prefrontal cortex of the macaque monkey. J. Neurosci., 13, 2982 2992.
45. Williamson, T.L. Cleveland, D.W. (1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci., 2, 50 56.
46. Wood, J.D., Beaujeux, T.P. Shaw, P.J. (2003) Protein aggregation in motor neurone disorders. Neuropathol. Appl. Neurobiol., 29, 529 545.
47. Xiao, S., McLean, J. Robertson, J. (2006) Neuronal intermediate filaments and ALS: a new look at an old question. Biochim. Biophys. Acta, 1762, 1001 1012.
48. Xu, Z. (2000) Mechanism and treatment of motoneuron degeneration in ALS: what have SOD1 mutants told us? Amyotroph. Lateral Scler. Other Motor Neuron Disord., 1, 225 234.
49. Yabe, J.T., Jung, C., Chan, W.K. Shea, T.B. (2000) Phospho-dependent association of neurofilament proteins with kinesin in situ. Cell. Motil. Cytoskeleton, 45, 249 262.
50. Zang, D.W., Lopes, E.C. Cheema, S.S. (2005) Loss of synaptophysin- positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS. J. Neurosci. Res., 79, 694 699.
51. Zhang, B., Tu, P., Abtahian, F., Trojanowski, J.Q. Lee, V.M. (1997) Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol., 139, 1307 1315.